Member Directory


The Wistar Institute


3601 Spruce Street
Philadelphia, PA 19104-4268

Main Contact: Dr. Dario Altieri, MD

http://www.wistar.org/


Business Description:

Research & Development, Focus On Anti-Cancer Systems & Vaccine Development


Business Type:


Business Information:

  • Established in 1892
  • Middle Market
  • Non Profit
  • Member Since 1996

RECENT POSTS

  • JUN
    20
  • The Noreen O'Neill Melanoma Research Symposium

    Tuesday, June 20, 2017 12:00 AM

    Posted on 6/14/2017 by Mrs. Tara Yates of

    The past decade has seen tremendous advances in the treatment of melanoma with next generation approaches like targeted therapies, immunotherapies and combination therapies that have changed the disease outcome for many patients. Despite the success of these targeted strategies, therapeutic responses are often short-lived due to the rapid onset of drug resistance. Expanding our understanding of melanoma biology will help decode the mechanisms of innate and acquired resistance and drive the development of novel and improved targeted therapies.

    WHAT: The Noreen O'Neill Melanoma Research Symposium – Melanoma: Advances in Therapy and Biology

    WHEN: Tuesday, June 20, 2017, 9:00 a.m. - 4:30 p.m. (lunch provided)

    WHERE: The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104

    This symposium is free but registration is required.

    For More Information View Related Information

  • JUN
    22
  • Wistar's Women & Science Program - Your DNA: What does it mean to have a genetic cancer mutation and how does that inform cancer therapy?

    Thursday, June 22, 2017 12:00 AM

    Posted on 6/14/2017 by Mrs. Tara Yates of

    Curious about the genetics of cancer and how cancer mutations may impact treatment decisions?

    Join The Wistar Institute at the Women & Science program and hear a special presentation by Maureen Murphy, Ph.D., a Wistar scientist whose impactful research focuses on genetic cancer mutations, variations and disparities. Learn more about how differences our genetic makeup affect our risk for cancer and how knowing this could lead to better treatments for patients.

    What: “Women & Science: Your DNA: What Does It Mean To Have A Genetic Cancer Mutation & How Does That Inform Cancer Therapy?”

    When: Thursday, June 22, 2017 at 6:00 pm

    Where: The Wistar Institute, 3601 Spruce Street, Philadelphia

    For More Information View Related Information

  • Default
  • THE WISTAR INSTITUTE WELCOMES NEW BOARD MEMBERS

    Posted on 11/9/2010 by Ms. Lee Christine Florida of

    The Wistar Institute recently welcomed two new members to its board of trustees:

    Vincent Price, Ph.D., is provost of the University of Pennsylvania and the Steven H. Chaffee Professor of Communication at the Annenberg School for Communication. Price has published extensively on the topics of mass communication and public opinion, social influence processes, and political communication. His current research focuses on the role of online political conversation and deliberation in shaping public opinion.

    Edward Ziff, Ph.D., is a professor of biochemistry and neural science at New York University, where he is also an adjunct professor of biology and an affiliate at the Center for Neural Science. Ziff maintains an active research lab in the department of biochemistry at the School of Medicine. His lab studies the regulation of AMPA receptors, glutamate-regulated cation channels that are found at excitatory synapses in the central nervous system.

    For More Information View Related Information

  • Default
  • TUMOR IMMUNOLOGIST JOSÉ R. CONEJO-GARCIA JOINS THE WISTAR INSTITUTE

    Posted on 9/14/2010 by Ms. Lee Christine Florida of

    (PHILADELPHIA – September 13, 2010) – The Wistar Institute has appointed ovarian cancer researcher José R. Conejo-Garcia, M.D., Ph.D., as associate professor in the Institute’s Immunology Program. Conejo-Garcia comes to Wistar from Dartmouth Medical School.

    Conejo-Garcia’s laboratory program explores an innovative approach to fighting ovarian cancer by exploiting the tumor’s reliance on its “microenvironment,” the collection of neighboring, healthy cells that nourish the tumor and enable it to thrive. In particular, he has developed a “Trojan Horse” method that reprograms white blood cells within the microenvironment – which otherwise have the effect of preventing the spontaneous anti-tumor activity of the immune system – so that they activate immune cells to attack the ovarian tumor.

    Read the full release at: http://www.wistar.org/news_info/pressreleases/pr_09.13.10.htm

    For More Information View Related Information

  • Default
  • LIFE SCIENCES LEADER NAMED CO-CHAIR OF GREATER PHILADELPHIA LIFE SCIENCES CONGRESS

    Posted on 9/10/2010 by Ms. Lee Christine Florida of

    PHILADELPHIA – September 9, 2010) – Russel E. Kaufman, M.D., president and CEO of The Wistar Institute, has been named co-chair of the Greater Philadelphia Life Sciences Congress (GPLSC), effective July 1, 2010. Kaufman joins Tom Muldoon, president of the Philadelphia Convention & Visitors Bureau (PCVB) as co-chair. Muldoon retires from PCVB this December.

    The GPLSC, a division of the Philadelphia Convention & Visitors Bureau, endorses and promotes Greater Philadelphia as a world-class life sciences meetings destination.

    Kaufman is a leading figure in the vibrant and growing life sciences industry in the Greater Philadelphia region. As president and CEO of The Wistar Institute, an independent, non-profit biomedical research institute and National Cancer Institute-designated Cancer Center in West Philadelphia, Kaufman works actively to speed progress along the path of scientific discovery from the laboratory to better treatments, preventions and cures for patients.

    For More Information View Related Information

My Benefit Advisor
PA Drug Card
Go to Top